1. Home
  2. FPI vs YDES Comparison

FPI vs YDES Comparison

Compare FPI & YDES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Farmland Partners Inc.

FPI

Farmland Partners Inc.

N/A

Current Price

$10.72

Market Cap

503.5M

Sector

Real Estate

ML Signal

N/A

YDES

YD Bio Limited Ordinary Shares

N/A

Current Price

$5.11

Market Cap

543.0M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
FPI
YDES
Founded
2013
2013
Country
United States
Taiwan
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Sector
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
503.5M
543.0M
IPO Year
2013
N/A

Fundamental Metrics

Financial Performance
Metric
FPI
YDES
Price
$10.72
$5.11
Analyst Decision
Hold
Analyst Count
1
0
Target Price
N/A
N/A
AVG Volume (30 Days)
292.6K
20.1K
Earning Date
04-29-2026
05-12-2026
Dividend Yield
3.14%
N/A
EPS Growth
N/A
N/A
EPS
0.01
N/A
Revenue
$52,178,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$1,070.50
N/A
Revenue Growth
N/A
N/A
52 Week Low
$9.37
$4.73
52 Week High
$13.23
$25.00

Technical Indicators

Market Signals
Indicator
FPI
YDES
Relative Strength Index (RSI) 33.72 38.14
Support Level $10.67 N/A
Resistance Level $11.06 $8.77
Average True Range (ATR) 0.22 0.34
MACD -0.10 0.08
Stochastic Oscillator 14.93 29.92

Price Performance

Historical Comparison
FPI
YDES

About FPI Farmland Partners Inc.

Farmland Partners Inc owns and seeks to acquire high-quality farmland throughout North America. The company is an internally managed real estate company which owns and contracts farmland and storage facilities located across the United States. Majority of the properties in its portfolio are used to grow primary crops, such as corn, soybeans, wheat, rice and cotton, and rest to produce specialty crops, such as almonds, pictachios, citrus, avacados, strawberies, and edible beans. The company generates its revenues through the rent it receives from its tenants.

About YDES YD Bio Limited Ordinary Shares

YD Bio Ltd is a biopharmaceutical company focusing on blood-based cancer detection, the development of stem cell- and exosome-based therapeutics with the potential to transform the treatment of a wide spectrum of diseases with high unmet medical need and serving as a trusted supplier of clinical testing drugs for pharmaceutical companies. Stem cell therapy uses versatile cells to repair or regenerate damaged tissues, offering innovative treatments for injuries, degenerative diseases, and immune disorders with potential for personalized medicine and tissue engineering.

Share on Social Networks: